Pneumonia Therapeutics Market Size, Share, Growth Report 2032

Pneumonia Therapeutics Market Size

The global pneumonia therapeutics market size was worth around USD 10.49 billion in 2023 and is predicted to grow to around USD 22.60 billion by 2032 with a compound annual growth rate (CAGR) of roughly 8.9% between 2024 and 2032.

The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD billion). The report covers a forecast and an analysis of the Pneumonia Therapeutics market on a global and regional level.

Request Free Sample

Pneumonia Therapeutics Market: Overview

Pneumonia is an inflammatory condition that affects the air sacs or alveoli in the lungs and may further lead to dry cough, chest pain, fever, breathing trouble, etc. It is generally caused by germs and bacteria and mainly affects the person already suffering from cold and flu. It can be life-threatening for infants, young children, and elderly people. It can be diagnosed with the help of blood tests, X-rays, physical examinations, etc. Vaccination helps in the prevention of pneumonia, whereas patients with severe condition patient need to be hospitalized and treated with oxygen therapy. Generally, antibiotics like quinolones, macrolides, etc. are used for treating pneumonia.

The global pneumonia therapeutics market is growing due to increasing air pollution and rising geriatric population across the globe. Environmental factors are also considered major factors for the growth of pneumonia therapeutics market globally. Various environmental wastes like chemicals catalyze the growth of fungi, virus, and bacteria. These microorganisms cause pneumonia. According to the World Health Organization, more than 1.6 million annual deaths of children under the age of five are caused by pneumonia. However, the lack of awareness among the population about diagnosis and treatment and traditional treatment for pneumonia may restrain the growth of the global pneumonia therapeutics market in the future.

Request Free Sample

Pneumonia Therapeutics Market: Segmentation

The study provides a decisive view of the pneumonia therapeutics market by segmenting it based on therapeutics, distribution channel, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

Based on therapeutics, the global pneumonia therapeutics market is segmented into prevention vaccines and treatment drugs. The prevention vaccines held the largest market share in terms of revenue in 2023, due to their high efficacy and precautionary effects. The treatment drugs segment is likely to show moderate growth in the years ahead, due to the wide availability of generic forms and growing resistance of antibiotics.

The distribution channel segment includes hospital pharmacy, retail pharmacy, and online pharmacy.

Pneumonia Therapeutics Market: Report Scope

Pneumonia Therapeutics Market: Regional Analysis

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. These regions are further segmented into the U.S., Canada, Germany, UK, France, China, Italy, Japan, India, and Brazil. 

By region, North America is expected to witness the highest CAGR over the forecast time period. This growth can be attributed to the increasing air pollution and growing release of hazardous chemicals in the environment. In Europe, the mortality rates for pneumonia are substantially higher in children up to four years and in adults aged 75 or over as compared to other age groups. This growth is mainly due to the increasing geriatric population and lifestyle-related ailments.

Pneumonia Therapeutics Market: Competitive Players

Some key participants operating in the global pneumonia therapeutics market include: 

• GlaxoSmithKline
• Sanofi
• Merck & Co. Inc.
• Novartis AG
• Eli Lilly and Company
• AstraZeneca
• Merck & Co.
• Pfizer
• Baxter International Inc.
• Allergan
• Lupin Pharmaceuticals Inc.

This report segments the global pneumonia therapeutics market into:

Global Pneumonia Therapeutics Market: Therapeutics Analysis

• Prevention Vaccines
• Treatment Drugs

Global Pneumonia Therapeutics Market: Distribution Channel Analysis

• Hospital pharmacy
• Retail pharmacy
• Online pharmacy

Global Pneumonia Therapeutics Market: Regional Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa